Ledger.Open graph →

SEC Form D · filed February 28, 2025

CoRegen, Inc

Offering

$10.0M

Sold

$10.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

ASPEN, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

David C. Lonard, Phd · Aspen, COExec Lee C. Fleisher, M.D · Aspen, CODirector Shawn C. Tomasello · Aspen, COExec · Director Steve C. Gorlin · Aspen, CODirector Clifford C. Dasco, M.D · Aspen, COExec · Director John C. Thomas, Jr · Aspen, COExec Edward J. Benz, Jr · Aspen, CODirector Jonathan W. Simons · Aspen, CODirector Bert W. O'Malley · Aspen, CODirector William C. Haseltine, Phd · Aspen, CODirector Steve C. Gorlin · Aspen, CODirector Clifford C. Dasco, M.D · Aspen, COExec · Director John C. Thomas, Jr · Aspen, COExec Bert W. O'Malley · Aspen, CODirector Edward J. Benz, Jr · Aspen, CODirector Jonathan W. Simons · Aspen, CODirector Lee C. Fleisher, M.D · Aspen, CODirector William C. Haseltine, Phd · Aspen, CODirector David C. Lonard, Phd · Aspen, COExec Shawn C. Tomasello · Aspen, COExec · Director Peter Park · San Francisco, CADirector Baruch E. Gross · Brooklyn, NYDirector Paras Malde · George Town, Grand Cayman, Cayman IslandsDirector Paras Malde · George Town, Grand Cayman, Cayman IslandsExec Kevin Mein · Lafayette, CAExec · Director Lauren Taylor Wolfe · New York, NYExec Matthew Frazier · Boston, MADirector Tim Woolaver · Grand Cayman, Cayman IslandsDirector Vadim Tulchinsky · Easthampton, MADirector Joshua Carson · Chicago, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗